Meta Platforms Inc. (NASDAQ:META) is among the best stocks you’ll wish you bought sooner. On December 4, Citi reiterated its ...

HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechnology company advancing next-generation immunotherapies for oncology and autoimmune diseases, today presented new first-in-human data from ...

On his journey, Dunk encounters Egg (Dexter Sol Ansell), a plucky young boy determined to be his squire. So begins a ...

CNW/ - CCRM and CCRM Nordic AB have announced a strategic collaboration with IonQ, a global leader in quantum computing ...

Lyell management will host an investor webcast with presenting author and ronde-cel investigator Sarah M. Larson, MD, ...

Preliminary clinical evidence of Lisaftoclax overcoming venetoclax resistance in myeloid malignancies with a 31.8% overall ...

First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability among primarily R/R NPM1m, KMT2Ar, and NUP98r acute leuk ...

A piece of literary history is going up for auction this month in London: J.R.R. Tolkien’s very own writing desk. This piece ...

The FDA has granted priority review to a new drug application (NDA) seeking the approval of sonrotoclax (BGB-11417; BeOne ...

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...

The US Food and Drug Administration has approved Bristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19 ...